IBBQ

Fund Description
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Fund Profile
Fund Name Invesco Nasdaq Biotechnology ETF
Fund Exchange Ticker IBBQ
Fund Sponsor Invesco
Fund ISIN US46138G5999
Net Expense Ratio 0.00 %
Fund Inception Date 11 June 2021
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name NASDAQ Biotechnology Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 9 August 2022
Asset Under Management 23.65 Million (USD)
1 Month Total Return 4.49 %
Year To Date Return -12.45 %
1 Year Total Return -21.26 %
3 Year Annualized Total Return
NAV 20.7461
Share Outstanding 1,140,000
Top 10 Holdings (8 August 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0709101640
MODERNA INC MRNA EQUI 0.0686338466
AMGEN INC AMGN EQUI 0.0681249160
GILEAD SCIENCES INC GILD EQUI 0.0671780945
REGENERON PHARMACEUTICALS REGN EQUI 0.0642540331
ASTRAZENECA PLC-SPONS ADR AZN EQUI 0.0346367501
ILLUMINA INC ILMN EQUI 0.0329246618
SEAGEN INC SGEN EQUI 0.0310984561
BIOGEN INC BIIB EQUI 0.0301798941
ALNYLAM PHARMACEUTICALS INC ALNY EQUI 0.0264065433